Metraipolis › archive › dc_c2741f64652a

Model-informed safety management of tocilizumab for pediatric sJIA: a PBPK approach for dose-escalation and vaccination timing — Europe PMC PMID:42305545

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42305545
DOI
10.3389/fimmu.2026.1847997
License (as archived)
solo-consultazione
Archived
2026-10-31T23:03:13.163Z
SHA-256 of the archived text
4a9be6f331c070bd60e37b16d1b4e1d9af85c44721f4627a99052eb073d143b4
Stable URL of this page
https://metraipolis.com/documento/dc_c2741f64652a

How to cite

Model-informed safety management of tocilizumab for pediatric sJIA: a PBPK approach for dose-escalation and vaccination timing — Europe PMC PMID:42305545 — Europe PMC (en), https://europepmc.org/article/MED/42305545 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c2741f64652a (Metraipolis archive dc_c2741f64652a, sha256 4a9be6f331c070bd60e37b16d1b4e1d9af85c44721f4627a99052eb073d143b4)
BibTeX
@misc{dcc2741f64652a,
  title = {Model-informed safety management of tocilizumab for pediatric sJIA: a PBPK approach for dose-escalation and vaccination timing — Europe PMC PMID:42305545},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42305545},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c2741f64652a; sha256 4a9be6f331c070bd60e37b16d1b4e1d9af85c44721f4627a99052eb073d143b4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42305545. Agents can read the archived copy with the MCP tool read_document.